Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.
Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.
复制标题
阿尔茨海默氏病的躁动和烦恼:基于证据的治疗方法和黑盒警告。
DOI:
10.1007/s11920-015-0640-7
复制
发表时间:
2016-01
影响因子:
6.7
通讯作者:
Streim JE
中科院分区:
文献类型:
--
作者:
Koenig AM;Arnold SE;Streim JE
More than five million Americans suffer from Alzheimer’s disease (AD), and this number is expected to triple by 2050. While impairments in cognition, particularly memory, are typically the defining features of the clinical syndrome, behavioral symptoms are extremely common, affecting up to 90% of patients. Behavioral symptoms in AD can be difficult to manage and may require a combination of non-pharmacological and pharmacological approaches. The latter is complicated by FDA “black-box warnings” for the medication classes most often used to target these symptoms, and currently there are initiatives in place to limit their use. In this review, we describe common behavioral symptoms of AD—with a particular focus on the challenging symptoms of “agitation” and “irritability”—and discuss evidence-based approaches to their management. Ultimately, multidimensional approaches tailored to the patient and their environment are recommended, and evidence-based practices should be used when available.
登录
查看更多内容
影响因子:
4
作者:
Ma, Hui;Huang, Yinglin;Zhu, Gang
通讯作者:
Zhu, Gang
影响因子:
2.4
作者:
Burns, Alistair;Perry, Elaine;Ballard, Clive
通讯作者:
Ballard, Clive
影响因子:
38.1
作者:
Fong, Tamara G.;Tulebaev, Samir R.;Inouye, Sharon K.
通讯作者:
Inouye, Sharon K.
DOI:
10.1016/j.jamda.2014.12.018
发表时间:
2015-05-01
影响因子:
7.6
作者:
Brodaty, Henry;Connors, Michael H.;Ames, David
通讯作者:
Ames, David
影响因子:
6.7
作者:
Borisovskaya, Anna;Pascualy, Marcella;Borson, Soo
通讯作者:
Borson, Soo